CG Oncology, Inc. Common stock (CGON) Stock Analysis

CG Oncology, Inc. Common stock (CGON) is a publicly traded company in the HEALTHCARE sector. It trades at $59.23, carries a market capitalization of $5.22B. This page summarizes the public market data, fundamentals, and frequently asked questions for CGON, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $59.23
• Market Cap: $5.22B
• EPS: $-2.34
• 52-Week High: $75.50
• 52-Week Low: $23.65

Market Sentiment

CG Oncology, Inc. Common stock currently has a Neutral sentiment score of 0.10.

About CG Oncology, Inc. Common stock

None

GNG Research Analysis

GNG Research scores CG Oncology, Inc. Common stock (CGON) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for CGON.

Frequently Asked Questions

Does CGON pay dividends?

CG Oncology, Inc. Common stock (CGON) does not currently pay a regular dividend.

What is CGON's market cap?

CG Oncology, Inc. Common stock (CGON) has a market capitalization of $5.22B with a current stock price of $59.23.